Last update:

HIV & AIDS news

HIV & AIDS

Trial HIV vaccine triggers elusive and essential antibodies, pointing the way toward a successful vaccine

An HIV vaccine candidate developed at the Duke Human Vaccine Institute triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a 2019 clinical trial.

Medications

What is PrEP? Will it stop me getting HIV?

HIV prevention was allocated A$43.9 million over three years in this week's federal budget. Some $26m of this is for "PrEP" for people without access to Medicare.

HIV & AIDS

New research traces the spread of HIV in and from Indonesia

The HIV variant dominant in Indonesia was introduced from Thailand over multiple events. A Kobe University study traces where it came from and how it spread from there, offering possible insights into the development of treatments ...

HIV & AIDS

Group-based interventions address HIV stigma

Group-based interventions have the potential to address HIV-related stigma among adolescents living with the virus, finds a recent study from researchers at the Brown School at Washington University in St. Louis and Makerere ...

HIV & AIDS

Study highlights importance of early interventions to combat HIV

A study has compared the development of HIV reservoirs—locations in the body where the virus persists in a latent state—between patients who receive either early or late medical interventions. The findings highlight the ...

HIV & AIDS

Visa rules jeopardize HIV management, study finds

A Monash University sexual health expert has warned that an unintended consequence of Australia's migration rules could compromise Australia's goal to end the HIV epidemic by 2030.

HIV & AIDS

Perinatal transmission of HIV can lead to cognitive deficits

Perinatal transmission of HIV to newborns is associated with serious cognitive deficits as children grow older, according to a detailed analysis of 35 studies conducted by Georgetown University Medical Center neuroscientists. ...